Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ratner

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Nature Biotechnology|March 10, 2015
Roche spends $1 billion on Foundation Medicine's tumor profilingMark Ratner
Nature Biotechnology|April 9, 2005
Syrrx acquisition signals maturation of structure-based discoveryMark Ratner
Nature Biotechnology|October 8, 2005
Profile: Jean DeleageMark Ratner
Nature Biotechnology|September 10, 2014
Small biotech steers HDAC inhibitor to clinicMark Ratner
Nature Biotechnology|September 10, 2014
FDA pushes for control over laboratory-developed testsMark Ratner
Nature Biotechnology|October 10, 2014
Pharma partners with efforts to pool patient genotype and phenotype dataMark Ratner
Nature Nanotechnology|June 6, 2013
A brief history of molecular electronicsMark Ratner
Nature Biotechnology|October 10, 2013
Scripps boosts research coffers by selling reagents to Sigma-AldrichMark Ratner
Nature Biotechnology|July 9, 2014
Celgene shells out for antisense drugMark Ratner
Nature Biotechnology|July 9, 2014
Faster approval for breakthrough devicesMark Ratner
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Nature Biotechnology|March 10, 2015
Roche spends $1 billion on Foundation Medicine's tumor profilingMark Ratner
Nature Biotechnology|April 9, 2005
Syrrx acquisition signals maturation of structure-based discoveryMark Ratner
Nature Biotechnology|October 8, 2005
Profile: Jean DeleageMark Ratner
Nature Biotechnology|September 10, 2014
Small biotech steers HDAC inhibitor to clinicMark Ratner
Nature Biotechnology|September 10, 2014
FDA pushes for control over laboratory-developed testsMark Ratner
Nature Biotechnology|October 10, 2014
Pharma partners with efforts to pool patient genotype and phenotype dataMark Ratner
Nature Nanotechnology|June 6, 2013
A brief history of molecular electronicsMark Ratner
Nature Biotechnology|October 10, 2013
Scripps boosts research coffers by selling reagents to Sigma-AldrichMark Ratner
Nature Biotechnology|July 9, 2014
Celgene shells out for antisense drugMark Ratner
Nature Biotechnology|July 9, 2014
Faster approval for breakthrough devicesMark Ratner
Pageof 11